Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

08/02/2024

Feb 8, 2024 10:36 pm

Feb 8, 2024 10:27 pm

Feb 8, 2024 9:54 pm

Feb 8, 2024 9:40 pm

Feb 8, 2024 9:30 pm

Feb 8, 2024 9:20 pm

Feb 8, 2024 5:54 pm

Feb 8, 2024 5:51 pm

Feb 8, 2024 5:47 pm

Feb 8, 2024 5:44 pm

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29

08/02/2024

The 60th Session of the IARC Scientific Council takes place in Lyon on 7–9 Feb – International Agency for Research on Cancer (IARC)

Bishal Gyawali: We are super excited to announce our first Common Sense Oncology fellow, Haydeé Verduzco

We met Conf. Carmen Orban to discuss how ECO can support in implementing HPV elimination policies – European Cancer Organisation

Zainab Shinkafi-Bagudu: I was a panelist Project PINK BLUE’s World Cancer Day symposium

Isabel Mestres: Kigali and Nairobi are working very hard to Close The Care Gap

Justin Stebbing: The first time invariant natural killer cells has ever been used as a cell therapy

Paolo Tarantino: Few treatments in oncology allow to achieve more than 50% intracranial response rates, with durable efficacy

Carla Johnson: Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable

Guillermo Chantada: We are launching this gigantic effort by SIOP and we will present the results of mapping in Latin America

ESMO welcomes all the newly appointed Committee and Working Group Chairs

Headlines

08/02/2024

The 60th Session of the IARC Scientific Council takes place in Lyon on 7–9 Feb – International Agency for Research on Cancer (IARC)

Bishal Gyawali: We are super excited to announce our first Common Sense Oncology fellow, Haydeé Verduzco

We met Conf. Carmen Orban to discuss how ECO can support in implementing HPV elimination policies – European Cancer Organisation

Zainab Shinkafi-Bagudu: I was a panelist Project PINK BLUE’s World Cancer Day symposium

Isabel Mestres: Kigali and Nairobi are working very hard to Close The Care Gap

Justin Stebbing: The first time invariant natural killer cells has ever been used as a cell therapy

Paolo Tarantino: Few treatments in oncology allow to achieve more than 50% intracranial response rates, with durable efficacy

Carla Johnson: Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable

Guillermo Chantada: We are launching this gigantic effort by SIOP and we will present the results of mapping in Latin America

ESMO welcomes all the newly appointed Committee and Working Group Chairs

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap